121 related articles for article (PubMed ID: 14755196)
1. Role of the physician versus the patient in the detection of recurrent disease following treatment for head and neck cancer.
Agrawal A; deSilva BW; Buckley BM; Schuller DE
Laryngoscope; 2004 Feb; 114(2):232-5. PubMed ID: 14755196
[TBL] [Abstract][Full Text] [Related]
2. PET-CT and the detection of the asymptomatic recurrence or second primary lesions in the treated head and neck cancer patient.
Dunsky KA; Wehrmann DJ; Osman MM; Thornberry BM; Varvares MA
Laryngoscope; 2013 Sep; 123(9):2161-4. PubMed ID: 23817791
[TBL] [Abstract][Full Text] [Related]
3. [Post-treatment follow-up of head and neck cancer patients].
Graff P; Blanchard P; Thariat J; Racadot S; Lapeyre M
Cancer Radiother; 2019 Oct; 23(6-7):576-580. PubMed ID: 31422000
[TBL] [Abstract][Full Text] [Related]
4. The follow-up of patients with head and neck cancer: an analysis of 1,039 patients.
Kothari P; Trinidade A; Hewitt RJD; Singh A; O'Flynn P
Eur Arch Otorhinolaryngol; 2011 Aug; 268(8):1191-1200. PubMed ID: 21193920
[TBL] [Abstract][Full Text] [Related]
5. Recurrent head and neck cancer: United Kingdom National Multidisciplinary Guidelines.
Mehanna H; Kong A; Ahmed SK
J Laryngol Otol; 2016 May; 130(S2):S181-S190. PubMed ID: 27841130
[TBL] [Abstract][Full Text] [Related]
6. Surveillance of Patients with Head and Neck Cancer with an Intensive Clinical and Radiologic Follow-up.
Imbimbo M; Alfieri S; Botta L; Bergamini C; Gloghini A; Calareso G; Orlandi E; Iacovelli NA; Guzzo M; Granata R; Resteghini C; Locati L; Volpi CC; Licitra L; Bossi P
Otolaryngol Head Neck Surg; 2019 Oct; 161(4):635-642. PubMed ID: 31286827
[TBL] [Abstract][Full Text] [Related]
7. Self-reported Symptoms to Monitor Recurrent Head and Neck Cancer-Analysis of 1,678 Cases.
Boysen ME; Zätterström UK; Evensen JF
Anticancer Res; 2016 Jun; 36(6):2849-54. PubMed ID: 27272796
[TBL] [Abstract][Full Text] [Related]
8. Clinical Practice Guideline: Evaluation of the Neck Mass in Adults.
Pynnonen MA; Gillespie MB; Roman B; Rosenfeld RM; Tunkel DE; Bontempo L; Brook I; Chick DA; Colandrea M; Finestone SA; Fowler JC; Griffith CC; Henson Z; Levine C; Mehta V; Salama A; Scharpf J; Shatzkes DR; Stern WB; Youngerman JS; Corrigan MD
Otolaryngol Head Neck Surg; 2017 Sep; 157(2_suppl):S1-S30. PubMed ID: 28891406
[TBL] [Abstract][Full Text] [Related]
9. [Responsibilities of the otorhinolaryngologist in the follow-up of malignancies of the head and neck].
Tesche S; Metternich FU
HNO; 2006 Sep; 54(9):721-6; quiz 727-8. PubMed ID: 16705350
[TBL] [Abstract][Full Text] [Related]
10. The value of routine follow-up after treatment for head and neck cancer. A national survey from DAHANCA.
Pagh A; Vedtofte T; Lynggaard CD; Rubek N; Lonka M; Johansen J; Andersen E; Kristensen CA; von Buchwald C; Andersen M; Godballe C; Overgaard J; Grau C
Acta Oncol; 2013 Feb; 52(2):277-84. PubMed ID: 23320772
[TBL] [Abstract][Full Text] [Related]
11. A longitudinal study of follow-up activities after curative treatment for head and neck cancer.
Pagh A; Grau C; Overgaard J
Acta Oncol; 2015 May; 54(5):813-9. PubMed ID: 25907822
[TBL] [Abstract][Full Text] [Related]
12. Patients' and physicians' roles in detecting recurrent Hodgkin lymphoma following complete remission.
Bestawros A; Foltz L; Srour N; Savage KJ; Connors JM
Ann Oncol; 2013 May; 24(5):1359-63. PubMed ID: 23230136
[TBL] [Abstract][Full Text] [Related]
13. Posttreatment Imaging in Patients with Head and Neck Cancer without Clinical Evidence of Recurrence: Should Surveillance Imaging Extend Beyond 6 Months?
Gore A; Baugnon K; Beitler J; Saba NF; Patel MR; Wu X; Boyce BJ; Aiken AH
AJNR Am J Neuroradiol; 2020 Jul; 41(7):1238-1244. PubMed ID: 32554418
[TBL] [Abstract][Full Text] [Related]
14. Factors affecting long-term survival in patients with recurrent head and neck cancer may help define the role of post-treatment surveillance.
Agrawal A; Hammond TH; Young GS; Avon AL; Ozer E; Schuller DE
Laryngoscope; 2009 Nov; 119(11):2135-40. PubMed ID: 19507214
[TBL] [Abstract][Full Text] [Related]
15. Making Time for Patients: Positive Impact of Direct Patient Reporting.
Mohan SK; Hudgins PA; Patel MR; Stapleton J; Duszak R; Aiken AH
AJR Am J Roentgenol; 2018 Jan; 210(1):W12-W17. PubMed ID: 29220209
[TBL] [Abstract][Full Text] [Related]
16. Association of Symptoms and Clinical Findings With Anticipated Outcomes in Patients With Recurrent Head and Neck Cancer.
Pipkorn P; Licata J; Kallogjeri D; Piccirillo JF
JAMA Otolaryngol Head Neck Surg; 2018 Aug; 144(8):738-745. PubMed ID: 30003215
[TBL] [Abstract][Full Text] [Related]
17. Planned neck dissection after concomitant radiochemotherapy for advanced head and neck cancer.
Frank DK; Hu KS; Culliney BE; Persky MS; Nussbaum M; Schantz SP; Malamud SC; Holliday RA; Khorsandi AS; Sessions RB; Harrison LB
Laryngoscope; 2005 Jun; 115(6):1015-20. PubMed ID: 15933512
[TBL] [Abstract][Full Text] [Related]
18. Adjuvant stereotactic body radiotherapy±cetuximab following salvage surgery in previously irradiated head and neck cancer.
Vargo JA; Kubicek GJ; Ferris RL; Duvvuri U; Johnson JT; Ohr J; Clump DA; Burton S; Heron DE
Laryngoscope; 2014 Jul; 124(7):1579-84. PubMed ID: 24123056
[TBL] [Abstract][Full Text] [Related]
19. Surveillance for recurrent head and neck cancer using positron emission tomography.
Lowe VJ; Boyd JH; Dunphy FR; Kim H; Dunleavy T; Collins BT; Martin D; Stack BC; Hollenbeak C; Fletcher JW
J Clin Oncol; 2000 Feb; 18(3):651-8. PubMed ID: 10653881
[TBL] [Abstract][Full Text] [Related]
20. Post-Treatment Head and Neck Cancer Care: National Audit and Analysis of Current Practice in the United Kingdom.
INTEGRATE (The UK ENT Trainee Research Network)
Clin Otolaryngol; 2021 Jan; 46(1):284-294. PubMed ID: 32734679
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
